Superdisintegrants Market Size & Growth Forecast 2027–2036, By Segments (Form, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Superdisintegrants Market size stood at USD 620.11 million in 2026 and is predicted to grow at a 5.04% CAGR from 2027 to 2036, surpassing USD 1.01 billion by 2036. The industry revenue for 2027 is estimated at USD 646.4 million.
Get more details on this report
Request Free Sample ReportSuperdisintegrants Market Intelligence Snapshot
Regional Market Dynamics
- North America leads the market through its mature pharmaceutical manufacturing base, strong demand for oral solid dosage forms, and consistent use of high-performance excipients for quality-focused production.
- Asia Pacific is expected to grow at a 6.1% CAGR as pharmaceutical manufacturing expands and drug producers increasingly adopt performance-oriented excipients to improve production efficiency and tablet performance.
Segment Momentum
- Tablets and capsules lead with 60.43% share as the most established oral solid dosage forms, widely using superdisintegrants for consistent breakdown and reliable drug release in standard manufacturing.
- Ion exchange resin is fastest-growing as manufacturers adopt more specialized excipients that support advanced formulation performance and differentiated drug delivery beyond traditional disintegration functions.
Market Expansion Drivers
- Expanding orally disintegrating tablet production increasing pharmaceutical demand for superdisintegrants.
- Rising geriatric and pediatric dysphagia cases accelerating fast-dissolving drug formulation adoption.
- Growing preference for natural excipients driving innovation in plant-based superdisintegrant solutions.
Leading Market Participants
- Top players in the superdisintegrants market include BASF SE (Germany), Ashland Inc. (United States), DuPont de Nemours, Inc. (United States), Roquette Frères S.A. (France), DFE Pharma GmbH & Co. KG (Germany), JRS Pharma GmbH & Co. KG (Germany), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Nippon Soda Co., Ltd. (Japan), Corel Pharma Chem (India).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 620.11 million
- 2027 Estimated Market Size: USD 646.4 million.
- Projected Market Size: USD 1.01 billion by 2036
- Growth Forecast: 5.04% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Tablets and Capsules (Form) | Crospovidone (Product)
- Emerging Opportunity Segment: Mouth-dissolving Films (Form) | Ion Exchange Resin (Product)
Market Growth Drivers and Industry Trends
Expanding orally disintegrating tablet production increasing pharmaceutical demand for superdisintegrants
The growing production of orally disintegrating tablets is creating greater demand for excipients that enable rapid tablet breakup and efficient drug release. In the superdisintegrants market, these functional ingredients are increasingly important in formulations designed to disperse quickly after administration, supporting convenient dosage forms for patients who have difficulty swallowing conventional tablets. Pharmaceutical manufacturers are also expanding their use of advanced formulation approaches to improve dissolution performance and patient acceptability, increasing the role of superdisintegrants in orally disintegrating and other immediate-release formulations.
Rising geriatric and pediatric dysphagia cases accelerating fast-dissolving drug formulation adoption
Difficulty swallowing among elderly and pediatric populations is encouraging greater interest in dosage forms that can be administered with minimal swallowing effort. Rising demand in the superdisintegrants market is linked to pharmaceutical formulations that rapidly disperse in the mouth and can improve ease of administration for patients with dysphagia. Fast-dissolving tablets can reduce dependence on conventional swallowing mechanisms and offer greater convenience for caregivers and patients, while their suitability for selected therapeutic applications supports broader formulation development targeting vulnerable patient groups.
Growing preference for natural excipients driving innovation in plant-based superdisintegrant solutions
Increasing attention toward naturally derived pharmaceutical ingredients is encouraging manufacturers to explore plant-based alternatives for excipient applications. The superdisintegrants market is being influenced by this preference as formulation developers investigate natural polymers and other renewable materials that can provide effective swelling, wicking, or disintegration properties. Interest in plant-derived excipients is also associated with formulation differentiation, consumer expectations around ingredient sourcing, and efforts to develop pharmaceutical products using materials perceived as more sustainable or naturally sourced.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding orally disintegrating tablet production increasing pharmaceutical demand for superdisintegrants | 2.00% | High | North America, Europe | High | Near Term |
| Rising geriatric and pediatric dysphagia cases accelerating fast-dissolving drug formulation adoption | 1.80% | Moderate | Europe, Asia Pacific | High | Mid Term |
| Growing preference for natural excipients driving innovation in plant-based superdisintegrant solutions | 1.40% | High | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the superdisintegrants market, North America held the largest share in 2026, reflecting its established pharmaceutical manufacturing base, advanced drug formulation capabilities, and strong emphasis on developing efficient oral solid dosage forms. The region benefits from sophisticated research and development infrastructure and extensive adoption of excipient technologies that can improve tablet performance, dissolution, and manufacturing consistency. Demand for patient-friendly dosage forms and continued innovation in pharmaceutical formulations are also supporting the use of high-performance superdisintegrants. Strong quality standards and regulatory attention to pharmaceutical manufacturing further encourage formulators to select reliable excipient technologies, sustaining the region's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, supported by expanding pharmaceutical production, increasing healthcare access, and rising demand for cost-effective and quality-focused drug formulations. Growth in domestic pharmaceutical manufacturing is encouraging greater utilization of specialized excipients that can enhance formulation performance and production efficiency. The expansion of generic drug production and increasing investments in modern manufacturing facilities are creating additional opportunities for superdisintegrants. At the same time, improving regulatory frameworks and technological capabilities are enabling pharmaceutical manufacturers across the region to adopt more advanced formulation approaches.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Focused ExcipientsGermany emphasizes superdisintegrants that meet stringent pharmaceutical quality standards and support advanced formulation development. Manufacturers focus on consistent excipient performance to enhance production efficiency and finished product reliability.
France 🇫🇷
Advanced Oral FormulationsFrance adopts superdisintegrants to support innovative oral drug formulations across branded and specialty pharmaceuticals. Manufacturers seek excipients that enhance patient convenience while aligning with evolving formulation requirements.
Italy 🇮🇹
Efficient Production MaterialsItaly focuses on superdisintegrants that improve manufacturing flexibility for oral solid dosage production. Pharmaceutical producers emphasize dependable excipient performance to optimize tablet quality across diverse therapeutic applications.
Japan 🇯🇵
Precision Tablet DevelopmentJapan prioritizes superdisintegrants for high-quality oral dosage formulations requiring rapid and predictable tablet performance. Pharmaceutical companies value excipients that integrate with sophisticated manufacturing processes while maintaining product consistency.
South Korea 🇰🇷
Generic Manufacturing SupportSouth Korea expands the use of superdisintegrants as pharmaceutical manufacturers strengthen generic drug production and formulation capabilities. Demand centers on versatile excipients that improve tablet performance while supporting efficient commercial-scale manufacturing.
United States 🇺🇸
Formulation InnovationThe U.S. superdisintegrants market is driven by pharmaceutical manufacturers developing patient-friendly oral solid dosage forms. Companies prioritize high-performance excipients that improve tablet disintegration while supporting continuous manufacturing and regulatory compliance.
Segment Leadership and Growth Trends
Superdisintegrants Market Share (%), by Form, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportForm Segment Analysis: Tablets and Capsules (Largest Segment) vs Mouth-dissolving Films (Fastest-Growing Segment)
The tablets and capsules segment dominated the superdisintegrants market in 2026, holding a 60.43% share. Tablets and capsules remain widely used oral dosage forms because of their convenience, established manufacturing processes, dosing flexibility, and suitability for large-scale pharmaceutical production. Superdisintegrants are particularly important in these formulations because they facilitate rapid breakdown after administration, supporting effective drug release. Continued demand for solid oral dosage forms and ongoing formulation optimization reinforce the segment's strong market position.
Mouth-dissolving films are gaining traction as pharmaceutical developers and consumers seek convenient dosage formats that can be administered without conventional swallowing requirements. These formulations can improve ease of administration and are particularly relevant for patients who experience difficulty swallowing conventional tablets or capsules. Growing interest in patient-centric drug delivery, rapid disintegration, and convenient administration is encouraging formulation development involving superdisintegrants for mouth-dissolving film applications.
Product Segment Analysis: Crospovidone (Largest Segment) vs Ion Exchange Resin (Fastest-Growing Segment)
Crospovidone accounted for the largest share of the superdisintegrants market in 2026, at 34.03%, supported by its established role in pharmaceutical formulations requiring efficient tablet disintegration. Its ability to promote rapid liquid uptake and facilitate tablet breakup makes it suitable for a broad range of solid dosage applications. Formulation developers value its performance, compatibility, and utility in supporting consistent drug release, sustaining demand across conventional pharmaceutical manufacturing.
Ion exchange resin is experiencing faster adoption as pharmaceutical formulation strategies increasingly focus on controlled drug delivery, taste masking, and improved patient acceptability. Its functional properties allow formulators to address specific delivery challenges while supporting the development of more sophisticated oral dosage systems. Rising interest in differentiated formulations and patient-friendly pharmaceutical products is creating additional opportunities for ion exchange resins within the superdisintegrants landscape.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Form | Tablets and Capsules, Mouth-dissolving Films | Tablets and Capsules | Mouth-dissolving Films |
| Product | Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resin, Others | Crospovidone | Ion Exchange Resin |
Competitive Landscape and Market Positioning
Major players in the superdisintegrants market:
1. BASF SE (Germany)
2. Ashland Inc. (United States)
3. DuPont de Nemours Inc. (United States)
4. Roquette Frères S.A. (France)
5. DFE Pharma GmbH & Co. KG (Germany)
6. JRS Pharma GmbH & Co. KG (Germany)
7. Asahi Kasei Corporation (Japan)
8. Merck KGaA (Germany)
9. Nippon Soda Co. Ltd. (Japan)
10. Corel Pharma Chem (India)
Rising demand for fast-dissolving pharmaceutical formulations is driving innovation in the superdisintegrants market. Advanced excipient technologies are improving tablet disintegration speed and drug absorption efficiency. Continuous formulation refinement is strengthening pharmaceutical performance in the superdisintegrants market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| BASF SE (Germany) | |||||||
| Ashland Inc. (United States) | |||||||
| DuPont de Nemours Inc. (United States) | |||||||
| Roquette Frères S.A. (France) | |||||||
| DFE Pharma GmbH & Co. KG (Germany) | |||||||
| JRS Pharma GmbH & Co. KG (Germany) | |||||||
| Asahi Kasei Corporation (Japan) | |||||||
| Merck KGaA (Germany) | |||||||
| Nippon Soda Co. Ltd. (Japan) | |||||||
| Corel Pharma Chem (India). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Ashland | Oct-23 | Ashland introduced its multifunctional Polyplasdone superdisintegrant incorporating glidant and lubricant properties. The innovation simplifies tablet manufacturing by reducing processing steps while improving tablet hardness and manufacturing consistency, supporting more efficient production of oral solid dosage formulations. |
| Ingredion Incorporated | Apr-23 | Ingredion Incorporated completed two strategic acquisitions in India to expand its presence in pharmaceutical ingredients. The investments significantly broaden the company's functional excipient portfolio, including superdisintegrants, binders, fillers, and lubricants, strengthening its manufacturing capabilities and competitive position in high-value pharmaceutical excipients. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Superdisintegrants Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| End User | Pharmaceutical Manufacturers, Contract Manufacturing Organizations, Nutraceutical Manufacturers, Research and Development Organizations |
| Drug Category | Immediate-Release Drugs, Orally Disintegrating Drugs, Modified-Release Drugs, Nutraceuticals |
| Distribution Channel | Direct Sales, Pharmaceutical Ingredient Distributors, Specialty Chemical Distributors, Online B2B Channels |
Superdisintegrants Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Pharmaceutical Formulation Trend Analysis |
|
| Excipient Innovation Opportunity Assessment |
|
| Sustainable Excipient Development Strategy |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the superdisintegrants market?
What is the forecasted size of the superdisintegrants industry?
How is the expansion of orally disintegrating tablets influencing demand in the superdisintegrants market?
Why are natural excipients shaping innovation in the superdisintegrants market?
Why do tablets and capsules dominate the superdisintegrants market?
Why is ion exchange resin the fastest-growing product in superdisintegrants?
What makes North America the leading superdisintegrants market?
Why is Asia Pacific experiencing rapid growth in the superdisintegrants market?
Which companies are driving growth in the superdisintegrants landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization